NYSE: TEVATeva Pharmaceutical Industries Revenue
Teva Pharmaceutical Industries revenue was $17.26B for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2025) ending on Dec 31, 2025 was $4.7B, up 5.2% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, TEVA annual revenue was $17.3B, with 4.3% growth year-over-year.
TEVA past revenue growth
How has TEVA's revenue growth performed historically?
Company
4.32%
Industry
4.32%
Market
91.52%
TEVA's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
TEVA's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
TEVA's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance
TEVA revenue history
Current Revenue
$17.3B
Current Earnings
$1.4B
Current Profit Margin
8.2%
TEVA's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance
Be the first to know when TEVA announces revenue.
TEVA Revenue History By Year
| TEVA Yearly Revenue | TEVA Revenue | TEVA Change | TEVA Revenue Growth |
|---|---|---|---|
| 2025-12-31 | $17.26B | $714.00M | +4.32% |
| 2024-12-31 | $16.54B | $698.00M | +4.40% |
| 2023-12-31 | $15.85B | $921.00M | +6.17% |
| 2022-12-31 | $14.93B | -$953.00M | -6.00% |
| 2021-12-31 | $15.88B | -$781.00M | -4.69% |
| 2020-12-31 | $16.66B | -$228.00M | -1.35% |
| 2019-12-31 | $16.89B | -$1.38B | -7.57% |
| 2018-12-31 | $18.27B | -$3.58B | -16.39% |
| 2017-12-31 | $21.85B | -$50.00M | -0.23% |
| 2016-12-31 | $21.90B | $2.25B | +11.45% |
| 2015-12-31 | $19.65B | -$620.00M | -3.06% |
| 2014-12-31 | $20.27B | -$42.00M | -0.21% |
| 2013-12-31 | $20.31B | -$3.00M | -0.01% |
| 2012-12-31 | $20.32B | $2.01B | +10.95% |
| 2011-12-31 | $18.31B | $2.19B | +13.59% |
| 2010-12-31 | $16.12B | $2.22B | +15.99% |
| 2009-12-31 | $13.90B | $2.81B | +25.39% |
| 2008-12-31 | $11.09B | $1.68B | +17.83% |
| 2007-12-31 | $9.41B | $1.00B | +11.89% |
| 2006-12-31 | $8.41B | $3.16B | +60.15% |
| 2005-12-31 | $5.25B | $451.00M | +9.40% |
| 2004-12-31 | $4.80B | $1.52B | +46.47% |
| 2003-12-31 | $3.28B | $757.80M | +30.09% |
| 2002-12-31 | $2.52B | $441.20M | +21.24% |
| 2001-12-31 | $2.08B | $327.50M | +18.72% |
| 2000-12-31 | $1.75B | N/A | N/A |
Teva Pharmaceutical Industries Revenue FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.